Atezolizumab,Bevacizumab,Pembrolizumab,Gemcitabine,Cisplatin,tremelimumab,durvalumab,Sorafenib
Roche,Merck,AstraZeneca,Pfizer
['gi ']
great summary by dr. vijayvergia in gi oral abstracts. #asco2023 
Medical oncologist: GI cancers & cancer of unknown primary + high quality & value-based cancer care delivery. @UTexasValue MSHCT student. Tweets mine.